The prognosis of patients with metastatic cervical cancer is poor with a median survival of 8–
13 months. Despite the potency of chemotherapeutic drugs, this treatment is rarely curative …

Cancer immunoinformatics have led to new directions towards vaccine design from
predicted potential epitope candidates, which are able to stimulate the correct cellular or …

Purpose Currently, therapeutic tumor vaccines under development generally lack significant
effects in human clinical trials. Exploring a powerful antigen delivery system is a potential …

The arsenal against different types of cancers has increased impressively in the last decade.
The detailed knowledge of the tumor microenvironment enables it to be manipulated in …

Целью исследования явилось изучение особенностей состояния клеточного и
гуморального иммунитета и функциональной активности нейтрофильных …

Hepatitis C virus (HCV) is known to cause hepatitis and hepatocellular carcinoma. E2
envelope glycoprotein of HCV type (HCV-E2) has been reported to bind human host cells …

Human papillomavirus (HPV) infection has been shown to be associated with human
tumorigenesis. The aim of the present study was to demonstrate the association between …

The Onchocerca volvulus activation-associated secreted protein-1 (Ov-ASP-1) has good
adjuvanticity for a variety of antigens and vaccines, probably due to its ability activate …

Methods PLGA polymers were used to form microspheres for a therapeutic vaccine against
cervical cancer. The target antigens were the L1 and L2 capsid proteins and the E6 and E7 …

ЦЕЛЬ. Оценка влияния комплекса пробиотических лактобактерий на эффективность
лечения и нормализацию иммунных нарушений при папилломавирусной инфекции у …